TaylorRH, LovellD, Menzies-GowN, LebrooySJ, MisiewicaJJ. Misleading response of malignant gastric ulcers to cimetidine.Lancet1978; 2: 686–7.
2.
ElderJB, GillespieIE, GanfuliPC. Cimetidine and gastric cancer.Lancet1979; 2: 1005–6.
3.
ReedPI, CassellPG, WaltersCI. Gastric cancer in patients who have taken cimetidine (letter).Lancet1979; 1: 1234–5.
4.
HawkerPC, MuscroftTJ, KeighleyMR. Gastric cancer after cimetidine in patient with two negative pretreatment biopsies.Lancet1980; 2: 709–10.
5.
StockbrueggerRW. Bacterial overgrowth as a consequence of reduced gastric acidity.Scand J Gastroenterol1985; 111(suppl): 7–16.
6.
RuddellWS. Gastric cancer in patients who have taken cimetidine (letter).Lancet1979; 1: 1234.
7.
LijinskyW, ReuberM. Comparison of nitrosocimetidine with nitrosomethylnitroguanidine in chronic feeding tests in rats.Cancer Res1984; 44: 447–9.
8.
ThomasJM, MisiewiczG. Histamine H2 receptor antagonists in the short- and long-term treatment of duodenal ulcer.Clin Gastroenterol1984; 13: 501–41.
9.
ReedPI, HainesK, SmithPL, HousePLJ, WalterCL. Effect of cimetidine on gastric juice N-nitrosamine concentration.Lancet1981; 1: 553–6.
10.
RuddellWSJ, AxonATR, FindlayJM, BartholomewBA, HillMJ. Effect of cimetidine on the gastric bacterial flora.Lancet1980; 1: 672–4.
11.
StockbrueggerRW, CottonPB, EugenidesN, BartholomewBA, HillMJ, WaltersCL. Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment.Gut1982; 23: 1048–54.
12.
MuscroftTJ, BourdonDW, YoungsDJ, KeighleyMR. Cimetidine is unlikely to increase formation of intragastric N-nitroso-compounds in patients taking a normal diet.Lancet1981; 1: 408–10.
13.
Milton-ThompsonGJ, AhmetZ, LightfootNF. Intragastric acidity, bacteria, nitrite, and N-nitroso compounds before, during and after cimetidine treatment.Lancet1982; 2: 1091–5.
FosterAB, JarmanM, MansonD. Structure and reactivity of nitrosocimetidine.Cancer Lett1980; 9: 47–52.
19.
CreanGP, LeslieGB, RoeFJ. Cimetidine and gastric cancer: negative studies in dogs.Lancet1979; 2: 797–8.
20.
JensenD. Denitrosation as a determinant of nitrosocimetidine in vivo activity.Cancer Res1983; 43: 5258–67.
21.
BrimblecombeRW, LeslieGB, WalkerTF. Toxicology of cimetidine.Hum Toxicol1985; 4: 13–25.
22.
AndersonLM, Giner-SorollaA, HallerIM, BudingerJM. Effects of cimetidine, nitrite, cimetidine plus nitrite, and nitrosocimetidine on tumors in mice following transplacental plus chronic lifetime exposure.Cancer Res1985; 45: 3561–6.
23.
CreanGP, MorsonBC, LeslieGB, RoeFJ. Cimetidine: further evidence of noncarcinogenicity in dogs (letter).N Engl J Med1981; 304: 672.
24.
HabsM, EisenbrandG, SchmahlD. No evidence of carcinogenicity of N-nitrosocimetidine in rats.Hepatogastroenterology1982; 29: 265–6.
25.
NeeJ, O'HIGGINSN, OsborneDH, PurdyS. The role of histamine antagonists on the development of experimental cancer in the rat.Ir J Med Sci1984; 153(10): 332–5.
26.
Collin-JonesDG, LangmanMJ, LawsonDH, VesseyMP. Post-marketing surveillance of the safety of cimetidine: 12 month mortality report.Br Med J1983; 286: 1713–6.
27.
Collin-JonesDG, LangmanMJ, LawsonDH, VesseyMP. Cimetidine and gastric cancer: preliminary report from postmarketing surveillance study.Br Med J1982; 285: 1311–3.
28.
PorterJB, JanewayCM, HunterJR. Absence of causal association between cimetidine and gastric cancer.Gastroenterology1984: 4: 987–8.
29.
PorterJB, JickH, PereraDR, YlvisakerJT, HunterJR. Long-term follow-up study of cimetidine.Pharmacotherapy1984; 4: 381–4.
30.
WaterhouseJ, MuirC, ShanmugaratnamK, PowellJ, eds. Cancer in five continents. Vol. 4. Lyon: WHO International Agency for Research on Cancer, 1982; IARC Scientific Publication no. 42.
31.
HillMJ. Gastric cancer in patients who have taken cimetidine (letter).Lancer1979; 1: 1235.
32.
StoddardCJ, SmithJA, JohnsonAG. Cimetidine, delay in diagnosis, and carcinoma of the stomach.Lancet1980; 2: 199–200.